Skip to main content
OpenTrials
Completed

NCT Number: NCT04262713

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery

A normative development concerning the mechanical resistance tests of the the femoral stems led to contraindicate, in September 2014, to implant Meije Duo ™ femoral stems size 1 or 2 in patients weighing more than 60 kg due to an assumed risk of femoral stem breakage.

This contraindication is based on standardized mechanical tests which may have not taken into account the changes in patient weight that may occur after the intervention.

To date, investigators have not been aware of any Meije Duo ™ size 1/2 brakeage in our patients implanted with this type of prosthesis regardless of their weights before 2014. However, it is possible that some of them have had a prostheses failure and consulted another hospital. In the absence of a clinical study on this problem, investigators decided to set up a health care assessment study collecting retrospective and prospective information from our patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, Île-de-France Region, France

Loading trial locations.

About this study

First, patients with Meije Duo ™sizes 1 or 2, who had surgery from 2007 to 2014, will be preselected on medical records.

The information notice will be sent to them by post. A period of reflection will be respected before contacting the patient to answer their questions concerning the research and its progress and obtain their oral consent to participate in the study.

After obtaining consent, investigators will enter the retrospective data collected in the medical and prospective file collected during this call.

Patients with at least one of the following criteria: weight> 60 kg and / or long neck / varus and / or DEVANE score ≥ 4, will be selected to have a hip X-ray which will be specially scheduled for the study.

This examination will tell us about the state of the prosthesis and of the underlying bone (broken stem, loosening of the implant, bone fracture, dislocation, border, etc.

It can be performed in our radiology department of the Diaconesses Croix Saint Simon hospital group or in another radiological center chosen by the patient if the latter cannot come to our hospital. In this case, a prescription for a hip X-ray will be sent to him by post to his current address as well as an information letter intended for the radiology office.

The patients who will be included in the study are implanted with Meije Duo ™ 1 and 2 between 2007 to 2014 and will all have a minimum follow-up of 4 years from the date of implantation. The maximum number of rupture complications is observed between the fourth and the eleventh year after fitting the prosthesis. All participants will therefore have a minimum of hindsight required for the evaluation of stem breaks. All of our patients will be contacted by telephone during the study period in chronological order of their previous management for obtaining consent, prospective data and for scheduling the hip radiography according to the criteria mentioned above.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

An x-ray of the hip concerned will be performed on all consenting patients, having at least one criterion of the following three during their medical history since the implantation of the hip prosthesis.

  • Weight> 60 kg
  • DEVANE score ≥ 4
  • Long neck / varus

Exclusion criteria

  • The patient expresses his opposition to the use of his personal data
  • Patients (<18 years old)
  • Patients unable or out of state to express their consent
  • Patient unable to speak French
  • Patient with memory impairment or cognitive impairment
  • Patient not affiliated to a social security or equivalent health coverage

Treatment and study plan

Radiographs

Other

Radiographs of the implanted hip with Meije duo size1 or 2 are performed in eligible patients ( Weigh>60, Long neck stem, Varus; DEVANE score ≥ 4)

Primary outcomes

  1. Pourcentage of participants who had stem (Meije DuoTM size 1 or 2) breakage occured between implantation and the study follow-up call phone.

    Time frame: Up to 4 weeks, starting from the call phone (patient consent)

    The number of stem breakage that occured since prostheses implantation will be collected by asking every participant during the follow-up call phone and performing hip xray to eligible ones (see above)

Secondary outcomes

  1. Pourcentage of participants who had other prostheses failures (loosening of the prosthesis, femoral fracture, dislocation)

    Time frame: Up to 4 weeks, starting from the call phone (patient consent)

    The number of prostheses failures that occured since the implantation will be collected by asking every participant during the follow-up call phone and by performing hip xray to eligible ones (see above)

  2. The change of physical activity in participants from baseline (prostheses implantation) to study call-phone point time.

    Time frame: Change from baseline Devane score at postoperative 4 years

    With DEVANE questionnaire, investigator will assess physical activity of participants

  3. The change of the weight and the body mass index (BMI) of the patients after the implantation of Meije DuoTM rods size 1 or 2

    Time frame: Change from baseline weight and BMI at postoperative 4 years

    Preoperative weight and BMI of particpantS will be collected from the medical file and postopeartive weight and BMI during follow up call phone

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier Diaconesses Croix Saint-Simon

Other

Registry information

Acronym: MEIJE

Important dates

Study start
2019
Primary completion
2021
Study completion
2022
First posted
Feb 10, 2020
Registry last updated
Mar 23, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.